About Insitro
Insitro is a company based in San Francisco (United States) founded in 2018.. Insitro has raised $643.21 million across 3 funding rounds from investors including Verily, ARE and WuXi AppTec. The company has 257 employees as of December 31, 2023. Insitro has completed 1 acquisition, including Haystack Sciences. Insitro offers products and services including insitro Platform and Therapeutic Pipeline. Insitro operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Ultragenyx, among others.
- Headquarter San Francisco, United States
- Employees 257 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$643.21 M (USD)
in 3 rounds
-
Latest Funding Round
$400 M (USD), Series C
Mar 15, 2021
-
Investors
Verily
& 16 more
-
Employee Count
257
as on Dec 31, 2023
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Insitro
Insitro offers a comprehensive portfolio of products and services, including insitro Platform and Therapeutic Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Integrates data to accelerate drug discovery and development processes
Focuses on metabolism, oncology, and neuroscience for new medicines
Unlock access to complete
Unlock access to complete
Funding Insights of Insitro
Insitro has successfully raised a total of $643.21M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $400 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $400.0M
-
First Round
First Round
(22 Jul 2019)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Series C - Insitro | Valuation | CPP Investments | |
| Mar, 2020 | Amount | Series B - Insitro | Valuation | a16z | |
| Jul, 2019 | Amount | Series A - Insitro | Valuation | Arch Venture Partners , Foresite Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Insitro
Insitro has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include Verily, ARE and WuXi AppTec. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Insitro
Insitro has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Haystack Sciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Proprietary platform employed for small molecule drug discovery.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Insitro
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Insitro Comparisons
Competitors of Insitro
Insitro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Ultragenyx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Insitro
Frequently Asked Questions about Insitro
When was Insitro founded?
Insitro was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Insitro located?
Insitro is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Insitro a funded company?
Insitro is a funded company, having raised a total of $643.21M across 3 funding rounds to date. The company's 1st funding round was a Series A of $100M, raised on Jul 22, 2019.
How many employees does Insitro have?
As of Dec 31, 2023, the latest employee count at Insitro is 257.
What does Insitro do?
Insitro was founded in 2018 and is headquartered in San Francisco, United States. An AI-enabled technology platform is utilized by the company to advance drug discovery and development. Focus is placed on infectious diseases such as HIV and hepatitis C, alongside cancer and genetic conditions like cystic fibrosis. Operations center on integrating machine learning with biological data to identify therapeutic targets in the biotechnology sector.
Who are the top competitors of Insitro?
Insitro's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
What products or services does Insitro offer?
Insitro offers insitro Platform and Therapeutic Pipeline.
How many acquisitions has Insitro made?
Insitro has made 1 acquisition, including Haystack Sciences.
Who are Insitro's investors?
Insitro has 17 investors. Key investors include Verily, ARE, WuXi AppTec, BlackRock, and Mubadala.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.